Increased site-specific phosphorylation of tyrosine hydroxylase accompanies stimulation of enzymatic activity induced by cessation of dopamine neuronal activity

Molecular Pharmacology

Volumn 55, Issue 2, 1999, Pages 202-209

  Lew, Jow Y ^a   Garcia Espana, Antonio ^a   Lee, Kwan Y ^a   Carr, Kenneth D ^a   Goldstein, Menek ^a   Haycock, John W ^b   Meller, Emanuel ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE AUTORECEPTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; ELECTROSTIMULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033017876     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.55.2.202     Document Type: Article

References (41)

1. Bedard P, Carlsson A and Lindqvist M (1972) Effect of a transverse cerebral hemisection on 5-hydroxytryptamine metabolism in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 272:1-15.
2. Berresheim U and Kuhn DM (1994) Dephosphorylation of tyrosine hydroxylase by brain protein phosphatases: A predominant role for type 2A. Brain Res 637:273-276.
3. Bohmaker K, Puza T, Goldstein M and Meller E (1989) Absence of spare autoreceptors regulating dopamine agonist inhibition of tyrosine hydroxylation in slices of rat striatum. J Pharmacol Exp Ther 248:97-103.
4. Bunney BS and Grace AA (1978) Acute and chronic haloperidol treatment. Comparison of effects on nigral dopaminergic cell activity. Life Sci 23:1715-1727.
5. Campbell DG, Hardie DG and Vulliet PR (1986) Identification of four phosphorylation sites in the N-terininal region of tyrosine hydroxylase. J Biol Chem 261: 10489-10492.
6. Chiodo LA and Bunney BS (1983) Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3:1607-1619.
7. De Lean A, Munson P and Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay and physiological dose-response curves. Am J Physiol 235:E97-E102.
8. 2+-dependent phosphorylation. Nature (Lond) 302:830-832.
9. El Mestikawy S and Hamon M (1986) Is dopamine-induced inhibition of adenylate cyclase involved in the autoreceptor-mediated negative control of tyrosine hydroxylase in striatal dopaminergic terminals? J Neurochem 47:1425-1433.
10. Goldstein M, Lee KY, Lew JY, Harada K, Wu J, Haycock JW, Hokfelt T and Deutch AY (1995) Antibodies to a segment of tyrosine hydroxylase phosphorylated at serine 40. J Neurochem 64:2281-2287.
11. Haavik J, Schelling DL, Campbell DG, Andersson KK, Flatmark T and Cohen P (1989) Identification of protein phosphatase 2A as the major tyrosine hydroxylase phosphatase in adrenal medulla and corpus striatum: Evidence from the effects of okadaic acid. FEBS Lett 251:36-42.
12. Harada K, Lew, JY, Garcia-Espana, A, Platt, J, Goldstein, M, Haycock, JW and Deutch, A (1996a) Acute haloperidol increases the activity and phosphorylation of tyrosine hydroxylase at specific serine sites in vivo. Soc Neurosci Abstr 22:376.
13. Harada K, Wu J, Haycock JW and Goldstein M (1996b) Regulation of L-DOPA biosynthesis by site-specific phosphorylation of tyrosine hydroxylase in AtT-20 cells expressing wild-type and serine 40-substituted enzyme. J Neurochem 67: 629-635.
14. Haycock JW (1990) Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, and 40. J Biol Chem 265:11682-11691.
15. Haycock JW and Haycock DA (1991) Tyrosine hydroxylase in rat brain dopaminergic nerve terminals. Multiple-site phosphorylation in vivo and in synaptosomes. J Biol Chem 266:5650-5657.
16. Haycock JW, Lew JY, Garcia-Espana A, Lee KY, Harada K, Meller E and Goldstein M (1998) Role of serine-19 phosphorylation in regulating tyrosine hydroxylase studied with site- and phospho-specific antibodies and site-directed mutagenesis. J Neurochem 71:1670-1675.
17. Hooper D, Kawamura M, Hoffman B, Kopin IJ, Hunyady B, Mezey E and Eisenhofer G (1997) Tyrosine hydroxylase assay for detection of low levels of enzyme activity in peripheral tissues. J Chromatogr Biomed Appl 694:317-324.
18. Kaufman S (1995) Tyrosine hydroxylase. Adv Enzymol Relat Areas Mol Biol 70:103-220.
19. Kehr W, Carlsson A and Lindqvist M (1977) Catecholamine synthesis in rat brain after axotomy: Interaction between apomorphine and haloperidol. Naunyn-Schmiedeberg's Arch Pharmacol 297:111-117.
20. Kumer SC and Vrana KE (1996) Intricate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem 67:443-462.
21. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 227:230-239.
22. Lazar MA, Mefford IN and Barchas JD (1982) Tyrosine hydroxylase activation. Comparison of in vitro phosphorylation and in vivo administration of haloperidol. Biochem Pharmacol 31:2599-2607.
23. Lerner P, Nose P, Gordon EK and Lovenberg W (1977) Haloperidol: Effect of long-term treatment on rat striatal dopamine synthesis and turnover. Science (Wash DC) 197:181-183.
24. Markey KA, Kondo H, Shenkman L, and Goldstein M (1980) Purification and characterization of tyrosine hydroxylase from a clonal pheochromocytoma cell line. Mol Pharmacol 17:79-85.
25. Meller E, Bohmaker K, Namba Y, Friedhoff AJ and Goldstein M (1987) Relationship between receptor occupancy and response at striatal dopamine autoreceptors. Mol Pharmacol 31:592-598.
26. Morgenroth VH, Walters JR and Roth RH (1976) Dopaminergic neurons-alteration in the kinetic properties of tyrosine hydroxylase after cessation of impulse flow. Biochem Pharmacol 25:655-661.
27. Murrin LC, Morgenroth VH and Roth RH (1976) Dopaminergic neurons: Effects of electrical stimulation on tyrosine hydroxylase. Mol Pharmacol 12:1070-1081.
28. Murrin LC and Roth RH (1987) Nigrostriatal dopamine neurons: modulation of impulse-induced activation of tyrosine hydroxylation by dopamine autoreceptors. Neuropharmacology 26:591-595.
29. Polli JW and Kincaid RL (1994) Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopaminergic innervation. J Neurosci 14:1251-1261.
30. Roth RH (1979) Dopamine autoreceptors: Pharmacology, function and comparison with post-synaptic dopamine receptors. Commun Psychopharmacol 3:429-445.
31. Salvatore MF, Garcia-Espana A, Goldstein M, Deutch A and Haycock JW (1998) Regulation of the phosphorylation state of tyrosine hydroxylase in vivo at multiple sites: Effects of haloperidol and raclopride in dorsal and ventral striatum. FASEB J 12:A456.
32. Segel IH (1975) Kinetics of unireactant enzymes, in Enzyme Kinetics, pp 64-71, Wiley-Interscience, New York.
33. Simon JR and Roth RH (1979) Striatal tyrosine hydroxylase: Comparison of the activation produced by depolarization and dibutyryl-cAMP. Mol Pharmacol 16: 224-233.
34. Strait KA and Kuczenski R (1986) Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase. Mol Pharmacol 29:561-569.
35. Walters JR and Roth RH (1976) Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors. Naunyn-Schmiedeberg's Arch Pharmacol 296:5-14.
36. Walters JR, Roth RH and Aghajanian GK (1973) Dopaminergic neurons: Similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigro- neostriatal pathway. J Pharmacol Exp Ther 186:630-639.
37. Wu J, Filer D, Friedhoff AJ and Goldstein M (1992) Site-directed mutagenesis of tyrosine hydroxylase. Role of serine 40 in catalysis. J Biol Chem 267:25754-25758.
38. Xu Z-Q, Lew JY, Harada K, Aman K, Goldstein M, Deutch A, Haycock JW and Hokfelt T (1998) Immunohistochemical studies on phosphorylation of tyrosine hydroxylase in central catecholamine neurons using site- and phosphorylation state-specific antibodies. Neuroscience 82:727-738.
39. Yamashita N, Miyashiro M, Baba J and Sawa A (1997) Rolipram, a selective inhibitor of phosphodiesterase type 4, pronouncedly enhanced the forskolin-induced promotion of dopamine biosynthesis in primary cultured rat mesencephalic neurons. Jpn J Pharmacol 75:91-95.
40. Zivkovic B, Guidotti A and Costa E (1975a) The regulation of striatal tyrosine hydroxylase. Effects of gamma hydroxybutric acid and haloperidol. Naunyn-Schmiedeberg's Arch Pharmacol 291:193-200.
41. Zivkovic B, Guidotti A and Costa E (1975b) The regulation of the kinetic state of striatal tyrosine hydroxylase and the role of postsynaptic dopamine receptors. Brain Res 92:516-521